SALKIN, H. Et Al. 2022. TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells. AMERICAN JOURNAL OF STEM CELLS , no.5 , 64-78.

SALKIN, H., YAY, A. H., Gokdemir, N. S., Goenen, Z. B., oezdamar, S., & YAKAN, B., (2022). TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells. AMERICAN JOURNAL OF STEM CELLS , no.5, 64-78.

SALKIN, HASAN Et Al. "TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells," AMERICAN JOURNAL OF STEM CELLS , no.5, 64-78, 2022

SALKIN, HASAN Et Al. "TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells." AMERICAN JOURNAL OF STEM CELLS , no.5, pp.64-78, 2022

SALKIN, H. Et Al. (2022) . "TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells." AMERICAN JOURNAL OF STEM CELLS , no.5, pp.64-78.

@article{article, author={HASAN SALKIN Et Al. }, title={TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells}, journal={AMERICAN JOURNAL OF STEM CELLS}, year=2022, pages={64-78} }